Researchers from the CNBP have released a new paper that examines the use of nanorubies for targeted bio-imaging activity. The work (lead author Varun Sreenivasan pictured) is trans-disciplinary in nature, drawing on the Centre’s collective knowledge in physics, pharmacology, chemistry, material science and embryology. The paper, published in ACS Applied Materials and Interfaces is accessible online.
Journal: ACS Applied Materials and Interfaces.
Publication title: Development of Bright and Biocompatible Nanoruby and its Application to Background-free Time-gated Imaging of G-protein Coupled Receptors.
Authors: Varun K. A. Sreenivasan, Wan Aizuddin W Razali, Kai Zhang, Rashmi R Pillai, Avishkar Saini, Denitza Denkova, Marina Santiago, Hannah Brown, Jeremy Thompson, Mark Connor, Ewa M. Goldys, and Andrei V Zvyagin.
Abstract: At the forefront of development of fluorescent probes for biological imaging applications are enhancements aimed at increasing their brightness, contrast, and photostability, especially towards demanding applications of single molecule detection. In comparison with existing probes, nanorubies exhibit unlimited photostability and a long emission lifetime (3.7 ms), which enable continuous imaging at single-particle sensitivity in highly scattering and fluorescent biological specimens. However, their wide application as fluorescence probes has so far been hindered by the absence of facile methods for scaled-up high volume production and molecularly-specific targeting. The present work encompasses large scale production of colloidally stable nanoruby particles, demonstration of their biofunctionality and negligible cytotoxicity, as well as validation of its use for targeted biomolecular imaging. In addition, optical characteristics of nanorubies are found to be comparable or superior to state-of-the-art quantum dots. Protocols of reproducible and robust coupling of functional proteins to the nanoruby surface are also presented. As an example, NeutrAvidin-coupled nanoruby show excellent affinity and specificity to µ-opioid receptors in fixed and live cells, allowing wide-field imaging of G-protein coupled receptors with single particle sensitivity.